CAH
NYSE · Health Care
Cardinal Health Inc
$211.31
+4.08 (+1.97%)
Performance
1D
—
1W
—
1M
—
3M
+1.45%
6M
+36.71%
1Y
+57.72%
YTD
+2.72%
Open$208.00
Previous Close$207.23
Day High$212.22
Day Low$207.92
52W High$230.81
52W Low$120.72
Volume—
Avg Volume1.79M
Market Cap52.54B
P/E Ratio31.61
EPS$6.95
SectorHealth Care
Technical Indicators
Full analysis →
SMA 50
$209.83
Above
SMA 200
$175.38
Above
RSI (14)
57.9
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
-31.6% upside
Current
$211.31
$211.31
Target
$144.52
$144.52
$93.37
$144.52 avg
$187.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 216.74B | 202.45B | 11.74B |
| Net Income | 1.52B | 1.28B | 1.71B |
| Profit Margin | 0.7% | 0.7% | 14.5% |
| EBITDA | 2.55B | 2.26B | 2.38B |
| Free Cash Flow | — | — | 2.03B |
| Rev Growth | +7.1% | +7.1% | +15.0% |
| Debt/Equity | 3.48 | 3.48 | 0.43 |
Dividend
Dividend Yield0.92%
Annual Dividend$2.05
Payout Ratio31.7%
Frequencyquarterly
Ex-Dividend—
Pay Date—
About Cardinal Health Inc
Cardinal Health, Inc. is one of the largest healthcare services and products companies in the United States, headquartered in Dublin, Ohio, operating as a distributor of pharmaceuticals and medical products to hospitals, pharmacies, surgery centers, and physician offices. The company is one of three dominant drug distributors in the country alongside McKesson and Cencora. Cardinal Health's two primary segments are Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution. The company also manufactures a range of medical and surgical products under private-label brands, serving health systems, specialty providers, and at-home patient care channels.
Health Care Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| UNH | UnitedHealth Group Inc | $270.55 | -0.64% | 21.7 | 261.12B |
| ABT | Abbott Laboratories | $104.83 | +0.74% | 28.3 | 184.68B |
| ISRG | Intuitive Surgical Inc | $469.98 | -0.41% | 59.8 | 170.78B |
| SYK | Stryker Corp | $327.65 | -0.26% | 39.5 | 128.28B |
| MDT | Medtronic Plc | $87.89 | +1.51% | 24.1 | 111.30B |
| MCK | Mckesson Corp | $879.75 | -0.25% | 25.1 | 109.03B |
CAH Frequently Asked Questions
What does Cardinal Health do?
Cardinal Health is one of three dominant distributors that move pharmaceutical products from manufacturers to hospitals, pharmacies, and clinics across the United States — an essential but low-margin function in the healthcare supply chain. The company also operates a medical products segment, distributing surgical supplies and operating its own manufacturing for certain branded medical products. The pharmaceutical distribution scale it shares with McKesson and Cencora creates high barriers to entry but also compresses margins, making volume and operational efficiency the keys to profitability.
Is CAH stock a good investment?
Cardinal Health has worked through significant headwinds including opioid litigation settlements and strategic restructuring of underperforming units, with the stock rebounding as clarity emerged on legal liabilities. The pharmaceutical distribution business is fundamentally stable — it handles the logistics of a necessary, growing industry — though margins are thin. GLP-1 drug distribution has become a volume tailwind as demand for weight-loss medications surged. Specialty distribution and at-Home services represent growth vectors with better margins than core drug distribution.
Who are Cardinal Health's main competitors?
McKesson Corporation is the largest pharmaceutical distributor in the United States, competing directly with Cardinal across the hospital, pharmacy, and specialty distribution markets. Cencora (formerly AmerisourceBergen) is the third member of the dominant triad, with particular strength in oncology and specialty drugs. Henry Schein competes in dental and medical supplies distribution. Owens & Minor competes in medical supplies distribution. Collectively, these three pharmaceutical distributors handle the overwhelming majority of drug distribution volume in the United States.
Does Cardinal Health pay dividends?
Cardinal Health has grown its quarterly dividend for over three decades, a streak that covers multiple business cycles, litigation events, and strategic pivots — a testament to the durability of pharmaceutical distribution cash flows. The dividend growth rate has been modest in recent years as the company managed opioid settlement payments, but the commitment to the dividend has remained firm. Yield is modest at current valuations, with management balancing dividends against share repurchases and debt management.
How much does CAH stock cost right now?
CAH last closed at $211.31, up 1.97% in the most recent trading session. Over the past 52 weeks, the stock has traded between a low of $120.72 and a high of $230.81. The current price represents 82% of its 52-week range, which helps investors gauge where the stock sits relative to its recent trading history.
What is the analyst consensus for CAH?
Among 22 analysts covering CAH, the consensus rating is Strong Buy — 19 rate it a buy, 3 hold, and 0 sell. The average price target sits at $144.52, implying 32% downside from the current price. Keep in mind that analyst targets reflect 12-month expectations and can shift quickly after earnings reports or major company events.
Does Cardinal Health Inc make money?
Cardinal Health Inc generated $216.74B in revenue during fiscal year 2026, with $1.52B reaching the bottom line as net income. The net profit margin of 0.7% reflects the competitive nature of its industry.
Is CAH stock expensive based on earnings?
CAH trades at a P/E ratio of 31.61 on trailing earnings of $6.95 per share. That's above the S&P 500 historical average, suggesting the market expects above-average earnings growth ahead. Comparing this multiple against Health Care sector peers gives better context than the broad market alone, since P/E norms vary significantly across industries.
Is CAH stock going up or down?
Performance varies across timeframes, reflecting shifting market conditions. Returns by timeframe: +1.45% (3M), +36.71% (6M), +57.72% (1Y), +2.72% (YTD). Comparing these figures against the S&P 500 and sector benchmarks helps determine whether CAH is outperforming or lagging the broader market.